Summary
Updated Aug 31, 2026
Albert L. Reese Jr. is Director of Lexaria Bioscience Corp. (LEXX). 1 SEC Form 4 filing on record, dated 15 May 2025.
Trading Pattern
InsiderAlpha's records for Albert L. Reese Jr. go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Albert L. Reese Jr.. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Christopher - $132K of LEXX open-market activity on record
- Christopher Bunka - $25K of LEXX open-market activity on record
- John Martin Docherty - $5K of LEXX open-market activity on record
- William Edward McKechnie - $5K of LEXX open-market activity on record
- Vanessa Carle - $683 of LEXX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Albert L. Reese Jr.?
Albert L. Reese Jr. is a corporate insider, tracked as Director of Lexaria Bioscience Corp. (LEXX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Albert L. Reese Jr. last file a Form 4?
The only primary Form 4 on record is dated 15 May 2025.
Where can I see all of Albert L. Reese Jr.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Albert L. Reese Jr. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial